ask="5.69"
ask_size="2400"
average_daily_volume="1629970"
bid="4.75"
bid_size="800"
book_value="0.21"
change="-0.03"
change_from_200_day_moving_average="0.12"
change_from_50_day_moving_average="-0.23"
change_from_52_week_high="-2.35"
change_From_52_week_low="2.34"
change_in_percent="-0.55%"
close="5.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71284000"
high="5.55"
high_52_weeks="7.80"
last_trade_date="2/3/2017"
last_trade_price="5.45"
last_trade_size="127384"
last_trade_time="4:00pm"
low="5.22"
low_52_weeks="3.11"
market_capitalization="577.48M"
moving_average_200_day="5.33"
moving_average_50_day="5.68"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="5.51"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="+2.29%"
percent_change_from_50_day_moving_average="-3.97%"
percent_change_from_52_week_high="-30.13%"
percent_change_from_52_week_low="+75.24%"
previous_close="5.48"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="26.35"
price_per_sales="20.57"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="15.67"
stock_exchange="NCM"
symbol="KERX"
volume="1540995"
weeks_range_52="3.11 - 7.80"
